Pediatric patients with essential thrombocythemia are mostly polyclonal and V617FJAK2 negative.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Blood

• Publication date

  2006-11-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2006-04-014746PMID 16849644
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders.

  2006cited by this paper
• Essential thrombocythemias without V617F JAK2 mutation are clonal hematopoietic stem cell disorders

  2006cited by this paper
• Normal thrombopoietin and its receptor (c‐mpl) genes in children with essential thrombocythemia

  2005cited by this paper
• Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.

  2005cited by this paper
• Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.

  2005cited by this paper
• JAK2 V617F Mutation in Essential Thrombocythemia: Clinical Associations and Long-Term Prognostic Relevance.

  2005cited by this paper
• A gain-of-function mutation of JAK2 in myeloproliferative disorders.

  2005cited by this paper
• JAK2V617F mutation in essential thrombocythaemia: clinical associations and long‐term prognostic relevance

  2005cited by this paper
• Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.

  2005cited by this paper
• The changing face of clinical trials

  2004cited by this paper
• Thrombocytosis.

  2004cited by this paper
• PRV‐1, erythroid colonies and platelet Mpl are unrelated to thrombosis in essential thrombocythaemia

  2004cited by this paper
• The chronic myeloproliferative disorders: clonality and clinical heterogeneity.

  2004cited by this paper
• Essential thrombocythaemia in children: is a treatment needed?

  2004cited by this paper
• Overexpression of the polycythemia rubra vera-1 gene in essential thrombocythemia.

  2002cited by this paper
• Features of essential thrombocythaemia in childhood: a study of five children

  2000cited by this paper
• A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications.

  1999cited by this paper
• Essential thrombocythemia in children.

  1999cited by this paper
• Acquired skewing of X‐chromosome inactivation patterns in myeloid cells of the elderly suggests stochastic clonal loss with age

  1997cited by this paper
• Clonal X-inactivation analysis of human tumours using the human androgen receptor gene (HUMARA) polymorphism: a non-radioactive and semiquantitative strategy applicable to fresh and archival tissue.

  1997cited by this paper
• Clonality analysis of hematopoiesis in essential thrombocythemia: advantages of studying T lymphocytes and platelets.

  1997cited by this paper
• Rapid determination of clonality by detection of two closely-linked X chromosome exonic polymorphisms using allele-specific PCR.

  1997cited by this paper
• Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction.

  1991cited by this paper
• A simple salting out procedure for extracting DNA from human nucleated cells.

  1988cited by this paper
• Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group.

  1986cited by this paper
• Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell.

  1981cited by this paper

• Pathomorphological diagnosis of Ph-negative chronic myeloproliferative neoplasms in children

  2024cites this paper
• Clinical and molecular characteristics of forty Chinese children with essential thrombocythemia: A single‐center, retrospective analysis

  2023cites this paper
• Essential Thrombocythemia in Children: A Retrospective Study

  2021cites this paper
• Perioperative Management of Polycythemia

  2021cites this paper
• Essential Thrombocythemia in Children and Adolescents

  2021cites this paper
• Thrombocytosis in Children

  2020cites this paper
• Essential thrombocythemia A retrospective case series

  2020cites this paper
• Human growth disorders associated with impaired GH action: Defects in STAT5B and JAK2.

  2020cites this paper
• Clinical features of children with polycythemia vera, essential thrombocythemia, and primary myelofibrosis in Japan: A retrospective nationwide survey

  2019cites this paper
• Portal vein thrombosis in a child with essential thrombocythemia seven years after diagnosis

  2019cites this paper
• The Liver in Systemic Illness

  2019cites this paper
• Pediatric Hepatology and Liver Transplantation

  2019influential citation
• Contemporary management of essential thrombocythemia in children

  2019cites this paper
• Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: a systematic review

  2019cites this paper
• Bone marrow histology for the diagnosis of essential thrombocythemia in children: a multicenter Italian study.

  2017cites this paper
• Genetic lesions and clinical implications in myeloproliferative neoplasms

  2017cites this paper
• Biomolecular and histological features in pediatric essential thrombocythemia: adequacy of who diagnostic criteria

  2017cites this paper
• JAK2+ Essential Thrombocythemia in a Young Girl With Budd-Chiari Syndrome: Diagnostic and Therapeutic Considerations When Adult Disease Strikes the Young

  2016cites this paper
• Nadpłytkowości pierwotne i wtórne u dzieci

  2015cites this paper
• Myeloproliferative neoplasms in children

  2015cites this paper
• Mutational profile of childhood myeloproliferative neoplasms

  2015cites this paper
• Are all cases of paediatric essential thrombocythaemia really myeloproliferative neoplasms? Analysis of a large cohort

  2015cites this paper
• Essential thrombocythemia with Mpl W515 K mutation in a child presenting with Budd–Chiari syndrome

  2015cites this paper
• Primary thrombocytosis in children

  2014cites this paper
• Haematological Maligancies Myeloproliferative Disorders

  2014cites this paper
• Idiopathic myelofibrosis in children: primary myelofibrosis, essential thrombocythemia, or transient process?

  2013cites this paper
• Paediatric essential thrombocythaemia: clinical and molecular features, diagnosis and treatment

  2013influential citation
• MPL W515L mutation in pediatric essential thrombocythemia

  2013cites this paper
• Asymtomatic Essential Thrombocythemia in a Child: A Rare Case Report

  2013cites this paper
• CAPÍTULO 4 – Diagnóstico y tratamiento de la trombocitemia esencial en la edad pediátrica

  2013cites this paper
• BRIEF REPORT MPL W515L Mutation in Pediatric Essential Thrombocythemia

  2013cites this paper
• Evaluation of the Presence of Hereditary and Acquired Thrombophilias in Brazilian Children and Adolescents With Diagnoses of Portal Vein Thrombosis

  2012cites this paper
• Mutations profile of polycythemia vera and essential thrombocythemia among Japanese children

  2012cites this paper
• Two cases of pediatric essential thrombocythemia managed effectively with hydroxyurea

  2012cites this paper
• Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome.

  2012cites this paper
• TROMBOSE DE VEIA PORTA EM CRIANÇAS E ADOLESCENTES: casuística e trombofilias associadas

  2011cites this paper
• CHAPTER 23 – Essential thrombocythemia and primary myelofibrosis

  2011cites this paper
• Heparin-Induced Thrombocytopenia in Patients with Philadelphia-Negative Myeloproliferative Disorders and Unusual Splanchnic or Cerebral Vein Thrombosis

  2010cites this paper
• Essential Thrombocythemia (ET)

  2010cites this paper
• Polycythemia Vera (PV)

  2010cites this paper
• Src tyrosine kinase preactivation is associated with platelet hypersensitivity in essential thrombocythemia and polycythemia vera.

  2010cites this paper
• Thrombotic complications in children with haematologic malignacies.

  2010cites this paper
• Essential thrombocythaemia in a teenage girl resulting in acquired von Willebrand syndrome with joint haemorrhage and menorrhagia

  2010cites this paper
• Essential thrombocythemia: past and present

  2009cites this paper
• JAK2V617F mutation-positive childhood essential thrombocythemia associated with cerebral venous sinus thrombosis.

  2009cites this paper
• polycythemia vera and essential thrombocythemia diseases are not appropriate for the diagnostic screening of childhood The revised WHO diagnostic criteria for Ph-negative myeloproliferative

  2009cites this paper
• Advances in Understanding and Management of Myeloproliferative Neoplasms

  2009cites this paper
• The mutant JAK2V617F allele burden in children with essential thrombocythemia

  2009cites this paper
• Childhood polycythemia vera and essential thrombocythemia: does their pathogenesis overlap with that of adult patients?

  2008cites this paper
• Epigenetic alteration of SOCS family members is a possible pathogenetic mechanism in JAK2 wild type myeloproliferative diseases

  2008cites this paper
• A CASE OF ESSENTIAL THROMBOCYTHEMIA IN AN 8-YEAR-OLD BOY

  2008influential citation
• The saga of JAK2 mutations and translocations in hematologic disorders: pathogenesis, diagnostic and therapeutic prospects, and revised World Health Organization diagnostic criteria for myeloproliferative neoplasms.

  2008cites this paper
• Childhood polycythemia vera and essential thrombocythemia: does their pathogenesis overlap with that of adult patients?

  2008cites this paper
• Frequency and clinical features of the JAK2 V617F mutation in pediatric patients with sporadic essential thrombocythemia

  2008cites this paper
• Most pediatric patients with essential thrombocythemia show hypersensitivity to erythropoietin in vitro, with rare JAK2 V617F-positive erythroid colonies.

  2008cites this paper
• Acute myocardial infarction: an unusual presentation of essential thrombocytosis in a 17-year-old man.

  2008cites this paper
• Thrombocytosis and thrombosis.

  2007cites this paper
• polycythemia vera and essential thrombocythemia diseases are not appropriate for the diagnostic screening of childhood

  2007cites this paper
• Essential versus reactive thrombocythemia in children: Retrospective analyses of 12 cases

  2007cites this paper
• Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia.

  2007cites this paper
• The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia.

  2007cites this paper
• Haemostatic proteins gene polymorphisms in patients with unusual vein thrombosis and Ph-myeloproliferative disorders

  2007cites this paper
• Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation.

  2007cites this paper
• Essential thrombocythemia in young individuals: frequency and risk factors for vascular events and evolution to myelofibrosis in 126 patients

  2007cites this paper
• Myeloid disease Who to transplant with chronic myelocytic leukemia in the tyrosine kinase era

  year unknowncites this paper